Table 1.
Correlations between the fold change in the expression levels of splicing machinery components (3rd year/baseline levels) and the fold change in relevant T2DM related parameters.
| Fold Change during Follow-Up | ||||
|---|---|---|---|---|
| Study Population (n = 215) Incident-T2DM + Non-T2DM Controls |
Incident-T2DM (n = 107) |
|||
| SPFQ | SRSF6 | |||
| Fold change during follow-up | HOMA-IR | ρ (rho) | −0.157 | |
| p | 0.03 * | |||
| HIRI | ρ (rho) | −0.176 | ||
| p | 0.018 * | |||
| HbA1c (%) | ρ (rho) | 0.227 | ||
| p | 0.047 * | |||
HbA1c: glycated hemoglobin; HOMA-IR: Homeostasis model assessment- insulin resistance; HIRI: Hepatic insulin resistance index; Non-significant correlations are not depicted. * indicates p < 0.05.